Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase Ib/II study of IBI188 with hypomethylating agents in acute myeloid leukemia
CTR20200938Phase 2Suspended
- Sponsor
- InnoCare Pharma
- Start
- Sep 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of letaplimab in acute myeloid leukemia (AML), sponsored by InnoCare Pharma. Started Sep 2020; status: suspended.
02
Drugs
letaplimab
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on CTR20200938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200938.